Savara (SVRA) Enterprise Value (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.97% |
| Dec 31, 2025 | -89.49% |
| Sep 30, 2025 | 15.04% |
| Jun 30, 2025 | 15.15% |
| Mar 31, 2025 | 12.11% |
| Dec 31, 2024 | 10.53% |
| Sep 30, 2024 | -80.46% |
| Jun 30, 2024 | 15.02% |
| Mar 31, 2024 | 11.84% |
| Dec 31, 2023 | 3.55% |
| Sep 30, 2023 | -60.12% |
| Jun 30, 2023 | 8.44% |
| Mar 31, 2023 | 8.81% |
| Dec 31, 2022 | 6.09% |
| Sep 30, 2022 | 5.91% |
| Jun 30, 2022 | 6.16% |
| Mar 31, 2022 | 5.81% |
| Dec 31, 2021 | 5.64% |
| Sep 30, 2021 | 5.48% |
| Jun 30, 2021 | 6.24% |
| Mar 31, 2021 | -134.50% |
| Dec 31, 2020 | 12.84% |
| Sep 30, 2020 | 5.34% |
| Jun 30, 2020 | 5.11% |
| Mar 31, 2020 | 13.78% |
| Dec 31, 2019 | -14.57% |
| Sep 30, 2019 | 4.88% |
| Jun 30, 2019 | -6.23% |
| Mar 31, 2019 | 5.10% |
| Dec 31, 2018 | 1.09% |
| Sep 30, 2018 | -49.89% |
| Jun 30, 2018 | 12.04% |
| Mar 31, 2018 | 9.89% |
| Dec 31, 2017 | -76.99% |
| Sep 30, 2017 | 12.84% |
| Jun 30, 2017 | -484.22% |
| Mar 31, 2017 | 21.75% |
| Dec 31, 2016 | 13.79% |
| Sep 30, 2016 | -10.34% |
| Jun 30, 2016 | 40.23% |
| Mar 31, 2016 | -40.99% |
| Dec 31, 2015 | 48.20% |
| Sep 30, 2015 | -51.82% |
| Jun 30, 2015 | 24.06% |
| Mar 31, 2015 | -120.16% |
| Dec 31, 2014 | 51.17% |
| Sep 30, 2014 | 1.46% |
| Jun 30, 2014 | 11.66% |
| Mar 31, 2014 | -16.23% |
| Dec 31, 2013 | 15.05% |
| Sep 30, 2013 | 43.41% |
| Jun 30, 2013 | -66.91% |
| Mar 31, 2013 | 12.33% |
| Dec 31, 2012 | 8.50% |
| Sep 30, 2012 | 7.37% |
| Jun 30, 2012 | 6.45% |
| Mar 31, 2012 | 9.19% |
| Dec 31, 2011 | -32.41% |
| Sep 30, 2011 | 8.73% |
| Jun 30, 2011 | 9.87% |
| Mar 31, 2011 | -66.38% |
| Dec 31, 2010 | 4.61% |
| Sep 30, 2010 | 5.87% |